Meiying Qi

1.4k total citations
18 papers, 1.1k citations indexed

About

Meiying Qi is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Meiying Qi has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Nephrology. Recurrent topics in Meiying Qi's work include Bone health and treatments (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Cell Adhesion Molecules Research (3 papers). Meiying Qi is often cited by papers focused on Bone health and treatments (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Cell Adhesion Molecules Research (3 papers). Meiying Qi collaborates with scholars based in United States and China. Meiying Qi's co-authors include Winson W. Tang, Sheila Scully, Gwyneth Van, David L. Lacey, Jeffrey S. Warren, Giorgio Senaldi, Shuangyi Yin, Arthur J. Wittwer, David E. Martin and Robert Z. Harris and has published in prestigious journals such as Blood, The Journal of Immunology and Endocrinology.

In The Last Decade

Meiying Qi

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiying Qi United States 16 486 316 272 259 151 18 1.1k
Arezoo Daryadel Switzerland 16 388 0.8× 352 1.1× 66 0.2× 255 1.0× 103 0.7× 32 940
Ayano Kondo United States 8 1.0k 2.1× 224 0.7× 285 1.0× 224 0.9× 34 0.2× 15 1.6k
Günther Staffler Austria 20 472 1.0× 118 0.4× 93 0.3× 529 2.0× 83 0.5× 29 1.4k
Kunimasa Yan Japan 23 561 1.2× 727 2.3× 83 0.3× 151 0.6× 41 0.3× 52 1.4k
Mien T.X. Nguyen United States 13 575 1.2× 146 0.5× 42 0.2× 171 0.7× 151 1.0× 14 1.0k
Jacqueline Hagège France 18 491 1.0× 348 1.1× 71 0.3× 191 0.7× 40 0.3× 32 1.2k
Rafia S. Al‐Lamki United Kingdom 17 410 0.8× 199 0.6× 120 0.4× 306 1.2× 34 0.2× 22 1.1k
Roslynn A. Stirzaker United States 8 555 1.1× 72 0.2× 220 0.8× 848 3.3× 41 0.3× 8 1.8k
Rachel Lotan Israel 15 581 1.2× 82 0.3× 43 0.2× 209 0.8× 29 0.2× 23 1000
Barry S. Rosen United States 10 599 1.2× 47 0.1× 99 0.4× 371 1.4× 39 0.3× 10 1.4k

Countries citing papers authored by Meiying Qi

Since Specialization
Citations

This map shows the geographic impact of Meiying Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiying Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiying Qi more than expected).

Fields of papers citing papers by Meiying Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiying Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiying Qi. The network helps show where Meiying Qi may publish in the future.

Co-authorship network of co-authors of Meiying Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Meiying Qi. A scholar is included among the top collaborators of Meiying Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiying Qi. Meiying Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Qi, Meiying, et al.. (2014). [Effects of sorafenib on proliferation and apoptosis of human multiple myeloma cell RPMI 8226].. PubMed. 22(5). 1331–5. 1 indexed citations
2.
Guzman, Roberto E., Eliane G. Valente, Efrain Pacheco, et al.. (2014). Expression of ORAI1, a Plasma Membrane Resident Subunit of the CRAC Channel, in Rodent and Non-rodent Species. Journal of Histochemistry & Cytochemistry. 62(12). 864–878. 18 indexed citations
3.
Liu, Xin, et al.. (2012). [Effects of docetaxel on proliferation and apoptosis of human multiple myeloma cell RPMI8226].. PubMed. 20(6). 1378–83. 1 indexed citations
4.
Nemeth, Edward F., Haynes Heaton, Michael A. Miller, et al.. (2004). Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl. Journal of Pharmacology and Experimental Therapeutics. 308(2). 627–635. 286 indexed citations
5.
Shalhoub, Victoria, Mario Grisanti, Sheila Scully, et al.. (2003). In Vitro Studies with the Calcimimetic, Cinacalcet HCl, on Normal Human Adult Osteoblastic and Osteoclastic Cells. Critical Reviews in Eukaryotic Gene Expression. 13(2-4). 18–18. 29 indexed citations
6.
Faggioni, Raffaella, Russell C. Cattley, Jane Guo, et al.. (2001). IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice. The Journal of Immunology. 167(10). 5913–5920. 101 indexed citations
7.
Fantuzzi, Giamila, David Reed, Meiying Qi, et al.. (2001). Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. European Journal of Immunology. 31(2). 369–375. 43 indexed citations
8.
Yan, Xiaoqiang, Ulla M. Sarmiento, Yu Sun, et al.. (2001). A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood. 98(13). 3793–3799. 84 indexed citations
9.
Capparelli, Casey, Paul J. Kostenuik, Sean Morony, et al.. (2000). Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.. PubMed. 60(4). 783–7. 122 indexed citations
10.
Clohisy, Denis R., Margaret L. Ramnaraine, Sheila Scully, et al.. (2000). Osteoprotegerin inhibits tumor‐induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. Journal of Orthopaedic Research®. 18(6). 967–976. 30 indexed citations
11.
Wang, Jinlin, Narumol Chinookoswong, Sheila Scully, Meiying Qi, & Zhiqing Shi. (1999). Differential Effects of Leptin in Regulation of Tissue Glucose Utilization in Vivo*. Endocrinology. 140(5). 2117–2124. 80 indexed citations
12.
Tang, Winson W., Gwyneth Van, & Meiying Qi. (1997). Myofibroblast and α1(III) collagen expression in experimental tubulointerstitial nephritis. Kidney International. 51(3). 926–931. 79 indexed citations
13.
Tang, Winson W., Meiying Qi, & Jeffrey S. Warren. (1996). Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney International. 50(2). 665–671. 97 indexed citations
14.
Tang, Winson W., et al.. (1996). Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis. Kidney International. 50(6). 1922–1927. 22 indexed citations
15.
Yi, Eunhee S., Hyesun Lee, Winson W. Tang, et al.. (1996). Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats.. PubMed. 149(4). 1303–12. 29 indexed citations
16.
Tang, Winson W., Shuangyi Yin, Arthur J. Wittwer, & Meiying Qi. (1995). Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. American Journal of Physiology-Renal Physiology. 269(3). F323–F330. 56 indexed citations
17.
Tang, Winson W., Eunhee S. Yi, Daniel G. Remick, et al.. (1995). Intratracheal injection of endotoxin and cytokines. IX. Contribution of CD11a/ICAM-1 to neutrophil emigration. American Journal of Physiology-Lung Cellular and Molecular Physiology. 269(5). L653–L659. 44 indexed citations
18.
Gerhardt, Elizabeth, et al.. (1991). The cDNA sequence and primary structure of the chicken transferrin receptor. Gene. 102(2). 249–254. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026